A New Paradigm for Clinical Trials in Antibiotherapy?
dc.contributor.author | Laupland, Kevin B. | |
dc.contributor.author | Fisman, David N. | |
dc.date.accessioned | 2018-09-27T12:00:03Z | |
dc.date.available | 2018-09-27T12:00:03Z | |
dc.date.issued | 2011-01-01 | |
dc.date.updated | 2018-09-27T12:00:03Z | |
dc.description.version | Peer Reviewed | |
dc.identifier.citation | Kevin B. Laupland and David N. Fisman, “A New Paradigm for Clinical Trials in Antibiotherapy?,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 22, no. 2, pp. 39-42, 2011. doi:10.1155/2011/412857 | |
dc.identifier.doi | https://doi.org/10.1155/2011/412857 | |
dc.identifier.uri | http://hdl.handle.net/1880/108426 | |
dc.identifier.uri | https://doi.org/10.11575/PRISM/45267 | |
dc.language.rfc3066 | en | |
dc.rights.holder | Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.title | A New Paradigm for Clinical Trials in Antibiotherapy? | |
dc.type | Journal Article |